These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8011150)

  • 1. Regulation of the immune response within privileged sites.
    Ksander BR; Streilein JW
    Chem Immunol; 1994; 58():117-45. PubMed ID: 8011150
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetic aspects of maternal-fetal relations.
    Clarke AG; Hetherington CM
    J Reprod Fertil Suppl; 1972 Mar; 15():99-118. PubMed ID: 4565753
    [No Abstract]   [Full Text] [Related]  

  • 4. Maternal and fetal immune responses during pregnancy.
    Sargent IL
    Exp Clin Immunogenet; 1993; 10(2):85-102. PubMed ID: 8251183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is tumor expression of the major histocompatibility complex antigen required for T cell immune surveillance?
    Liu Y; Zheng P
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S61-4. PubMed ID: 11665749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologically privileged sites.
    Barker CF; Billingham RE
    Adv Immunol; 1977; 25():1-54. PubMed ID: 345773
    [No Abstract]   [Full Text] [Related]  

  • 7. The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation.
    Shobu T; Sageshima N; Tokui H; Omura M; Saito K; Nagatsuka Y; Nakanishi M; Hayashi Y; Hatake K; Ishitani A
    J Reprod Immunol; 2006 Dec; 72(1-2):18-32. PubMed ID: 16806485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.
    Chen PW; Ksander BR
    Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G promotes immune tolerance.
    Rouas-Freiss N; Paul P; Dausset J; Carosella ED
    J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
    Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility antigen expression on the bovine placenta: its relationship to abnormal pregnancies and retained placenta.
    Davies CJ; Hill JR; Edwards JL; Schrick FN; Fisher PJ; Eldridge JA; Schlafer DH
    Anim Reprod Sci; 2004 Jul; 82-83():267-80. PubMed ID: 15271459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells and pre-eclampsia.
    Sargent IL; Borzychowski AM; Redman CW
    J Reprod Immunol; 2007 Dec; 76(1-2):40-4. PubMed ID: 17482272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunity, the trophoblast and decidua].
    Aguilar Parada E; Rábago Velasco M; Aguilar Ibarra MT; Moreno Cano H
    Ginecol Obstet Mex; 1993 Feb; 61():45-7. PubMed ID: 8406117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Materno-trophoblastic immunological balance.
    Labarrere CA; Faulk WP; McIntyre JA; Althabe OH
    Am J Reprod Immunol; 1989 Sep; 21(1):16-25. PubMed ID: 2695105
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune interactions at the maternal-fetal interface: a focus on antigen presentation.
    Huddleston H; Schust DJ
    Am J Reprod Immunol; 2004 Apr; 51(4):283-9. PubMed ID: 15212681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetomaternal immunotolerance.
    Makrigiannakis A; Karamouti M; Drakakis P; Loutradis D; Antsaklis A
    Am J Reprod Immunol; 2008 Dec; 60(6):482-96. PubMed ID: 19032609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of HLA-E and -F in pregnancy.
    Ishitani A; Sageshima N; Hatake K
    J Reprod Immunol; 2006 Apr; 69(2):101-13. PubMed ID: 16487601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.